Marc Beer’s Renovia and career background

Marc Beer has more than 25 years experience developing, commercializing biotechnology, pharmaceuticals, devices, and diagnostics. He holds a BS from the Miami University (Ohio) and he’s currently the co-founder of Renovia Inc. The startup of Renovia was all possible due to Marc raising over $42 million for the funding of the women’s health startup. The company was founded in 2016 and it specializes in products for pelvic disorders. The Boston-based company focuses on creating various therapeutic devices to treat hip disorders, for example like urinary problems. It’s been estimated these issues affect approximately 250 million women around the world. The first product to receive an FDA approval was Leva. The product was approved in April. Companies that have invested in Renovia are The Longwood Fund. The Longwood Fund invested early in Renovia’s startup. Their investment will go toward research, development and testing four more therapeutic, analytical, diagnostic products. Marc Beer addressed the public and stated that he’s thrilled to have the support and financial backing of leading healthcare investors. The vision he shares is to better diagnose, treat, and improve the lives of millions of women affected by pelvic floor disorders. With the digital health platform that’s given to the customers, valuable data will be provided to the customers on which treat options to choose from. This new technology provides greater knowledge and understating of pelvic floor disorders, with the ultimate goal of lowering long term healthcare costs.

 

In April 2000, before Marc Beer decide to venture into Renovia he was the Founding CEO of ViaCell. The company specializes in collecting, preserving, and developing blood stem cells from the umbilical cord. Within seven years he led the company from the beginning to a fast growing solid commercial organization. Under Marc’s leadership the company grew to over 300 employees and went public in 2005. Prior to his executive roles, he had a variety of sales and marketing roles in the pharmaceutical industry. In recognition to his alma mater, he decided to become a member of Miami University Business Advisory Council. Before this position, Marc was also a sitting member of the Notre Dame Research and Commercialization Advisory Committee. Also, he was advisory council to the Notre Dame Graduation Studies Research. Learn more: https://www.fiercebiotech.com/medtech/renovia-raises-42m-to-fund-digital-health-solutions-for-pelvic-floor-strengthening